Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who’ll be most likely to benefit from it.
Four Montrealers are participating in an innovative program at Yeshiva University (YU) this summer. Edith Baumberg and Hana Cohen, teachers at Solomon Schechter Academy of Montreal; Rabbi Yamin Benarroch, dean of students, student advisor, and teacher at Hebrew Academy in Cote St. Luc; and Shalom Spira are part of a program spearheaded by the Canadian Jewish community to train local Jewish educators and education professionals.
BRONX, NY — In their latest finding on the brain’s role in controlling appetite and weight, researchers at the Albert Einstein College of Medicine have shown that reducing levels of fatty acids in the hypothalamus causes rats to overeat and become obese. Their results suggest that restoring fatty-acid levels in the brain may be a promising way to treat obesity. The study, published in the January 15th on-line edition of Nature Neuroscience, was led by Dr. Luciano Rossetti, director of the Diabetes Research Center at Einstein. (The paper will appear in print in the February issue.)
Researchers at the Albert Einstein College of Medicine have identified a cellular protein that promotes atherosclerosis, the process that causes heart disease by narrowing coronary arteries. Therapies that inactivate this protein could offer an entirely new approach for combating heart disease, the leading cause of death among Americans.